PDL BioPharma, Inc. Net Aquisitions

Net Aquisitions of PDLI for past 10 years: annual, quarterly and twelve month trailing (TTM) including Net Aquisitions growth rates and interactive chart.


Highlights and Quick Summary

  • Net Aquisitions for the quarter ending December 30, 2016 was $-110 Million
  • Annual Net Aquisitions for 2016 was $-110 Million
Visit stockrow.com/PDLI for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow statement with 10 years of data, and state-of-the-art screener.

Historical Net Aquisitions of PDL BioPharma, Inc.

Most recent Net Aquisitionsof PDLI including historical data for past 10 years.

Interactive Chart of Net Aquisitions of PDL BioPharma, Inc.

PDL BioPharma, Inc. Net Aquisitions for the past 10 Years (both Annual and Quarterly)

(All values are in $ million)

Year Q1 Q2 Q3 Q4 Fiscal Year
2016 $-109.94 $-109.94

Business Profile of PDL BioPharma, Inc.

Sector: Other
Industry: Other
PDL BioPharma, Inc. manages various patents in the United States and internationally. The company's patents cover humanization of antibodies. It also offers notes and other long-term receivables services, as well as engages in the equity investment activities. The company was formerly known as Protein Design Labs, Inc. and changed its name to PDL BioPharma, Inc. in 2006. PDL BioPharma, Inc. was founded in 1986 and is headquartered in Incline Village, Nevada.